Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dolomite to Showcase Novel Microfluidic Solutions at MicroTAS 2013

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
Telos and Mitos Dropix to be showcased in Germany from 27th to 31st October.

Dolomite will be showcasing two devices, Telos and Mitos Dropix, on booth #6 at the 17th International Systems for Chemistry and Life Sciences (MicroTAS) in Freiburg, Germany, from the 27th to the 31st October.

The innovative Telos System is a breakthrough product for a wide range of industries requiring a microfluidic device capable of high throughput droplet, particle and flow product generation.

This modular, scalable, and highly flexible technology removes the low throughput limitation of individual microfluidic chips, enabling liters of droplets or particles to be produced in a day.

Each module accommodates a microfluidic chip with up to seven channels and, for maximum throughput, up to 10 modules can be linked to provide a total of 70 parallel channels; with tool-free module assembly and chip connection, set-up is rapid.

Telos features integrated valves for rapid start-up and individual chip control, and operates over a wide range of pressures and temperatures, from 0 to 10bar and 4 to 50°C, providing users with maximum flexibility.

The novel Mitos Dropix, developed in collaboration with the winner of Dolomite’s Productizing Science® Competition 2012, Drop-Tech Ltd, is a flexible, automated solution for droplet-on-demand applications.

Patented droplet ‘picking’ technology enables combinatorial droplet arrays to be created from multiple reagents off-chip and introduced into a flow-through microfluidic system, with accurate control of droplet size and frequency achieved via PC software.

This new high throughput screening format will prove an invaluable resource for basic research, drug discovery, cell-based studies and diagnostics applications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!